Farther Finance Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
2,906
+35
| +1% | +$15.6K | 0.03% | 496 |
|
|
2025
Q1 | $1.39M | Buy |
2,871
+462
| +19% | +$224K | 0.04% | 390 |
|
|
2024
Q4 | $970K | Buy |
2,409
+107
| +5% | +$43.1K | 0.04% | 378 |
|
|
2024
Q3 | $1.07M | Sell |
2,302
-10
| -0.4% | -$4.65K | 0.04% | 332 |
|
|
2024
Q2 | $1.09M | Buy |
2,312
+1,476
| +177% | +$696K | 0.05% | 286 |
|
|
2024
Q1 | $352K | Buy |
836
+108
| +15% | +$45.4K | 0.02% | 484 |
|
|
2023
Q4 | $296K | Buy |
728
+515
| +242% | +$210K | 0.02% | 447 |
|
|
2023
Q3 | $74.1K | Buy |
213
+68
| +47% | +$23.6K | 0.01% | 656 |
|
|
2023
Q2 | $51K | Buy |
145
+8
| +6% | +$2.82K | 0.01% | 667 |
|
|
2023
Q1 | $43.2K | Sell |
137
-37
| -21% | -$11.7K | 0.01% | 641 |
|
|
2022
Q4 | $50.2K | Buy |
+174
| New | +$50.2K | 0.02% | 484 |
|